Lisinopril in Black and African Ancestry Patients: Safety Profile Differences Explained
A clinical review of how lisinopril's safety and efficacy profile is discussed differently for Black and African ancestry patients, covering angioedema risk, blood-pressure response, ACE inhibitor pharmacogenomics, and guideline-based alternatives, with an explicit map of what is directly studied versus extrapolated.